Estimating the effects of multiple time-varying exposures using joint marginal structural models: Alcohol consumption, injection drug use, and HIV acquisition

Epidemiology

Volumn 23, Issue 4, 2012, Pages 574-582

  Howe, Chanelle J ^a   Cole, Stephen R ^b   Mehta, Shruti H ^c   Kirk, Gregory D ^c,d  

^a BROWN UNIVERSITY   (United States)

^b IL   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRINKING; DRUG USE; EXPOSURE; FEMALE; HAZARD RATIO; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JOINT MODEL; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MODEL; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; ALCOHOL DRINKING; CAUSALITY; COHORT STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); EFFECT MODIFIER, EPIDEMIOLOGIC; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84862128766     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/EDE.0b013e31824d1ccb     Document Type: Article

References (32)

1. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2008.
2. Van der Weele TJ. On the distinction between interaction and effect modification. Epidemiology. 2009;20:863-871.
3. Hernán MA, Brumback B, Robins JM. Marginal structural models to estimate the joint causal effect of non-randomized treatments. J Am Stat Assoc. 2001;96:440-448.
4. Tsiatis AA, Davidian M. An overview of joint modeling of longitudinal and time-to-event data. Statistica Sinica. 2004;14:793-818.
5. Robins JM, Hernán MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11:550-560.
6. Hernán MA, Brumback B, Robins JM. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology. 2000;11:561-570.
7. Nelson KE, Galai N, Safaeian M, Strathdee SA, Celentano DD, Vlahov D. Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988-1998. Am J Epidemiol. 2002;156:641-653.
8. Mehta SH, Galai N, Astemborski J, et al. HIV incidence among injection drug users in Baltimore, Maryland (1988-2004). J Acquir Immune Defic Syndr. 2006;43:368-372.
9. Plankey MW, Ostrow DG, Stall R, et al. The relationship between methamphetamine and popper use and risk of HIV seroconversion in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr. 2007;45: 85-92.
10. Taubman SL, Robins JM, Mittleman MA, Hernán MA. Intervening on risk factors for coronary heart disease: an application of the parametric g-formula. Int J Epidemiol. 2009;38:1599-1611.
11. Cole SR, Hernán MA, Robins JM, et al. Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models. Am J Epidemiol. 2003;158: 687-694.
12. Bodnar LM, Davidian M, Siega-Riz AM, Tsiatis AA. Marginal structural models for analyzing causal effects of time-dependent treatments: an application in perinatal epidemiology. Am J Epidemiol. 2004;159: 926-934.
13. Lopez-Gatell H, Cole SR, Hessol NA, et al. Effect of tuberculosis on the survival of women infected with human immunodeficiency virus. Am J Epidemiol. 2007;165:1134-1142.
14. Cook NR, Cole SR, Hennekens CH. Use of a marginal structural model to determine the effect of aspirin on cardiovascular mortality in the Physicians' Health Study. Am J Epidemiol. 2002;155:1045-1053.
15. Choi HK, Hernán MA, Seeger JD, Robins JM, Wolfe F. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet. 2002;359:1173-1177.
16. Zhang Y, Thamer M, Cotter D, Kaufman J, Hernán MA. Estimated effect of epoetin dosage on survival among elderly hemodialysis patients in the United States. Clin J Am Soc Nephrol. 2009;4:638-644.
17. Nandi A, Glass TA, Cole SR, et al. Neighborhood poverty and injection cessation in a sample of injection drug users. Am J Epidemiol. 2010; 171:391-398.
18. Yu AP, Yu YF, Nichol MB. Estimating the effect of medication adherence on health outcomes among patients with type 2 diabetes-an application of marginal structural models. Value Health. 2010;13:1038-1045.
19. Howe CJ, Cole SR, Ostrow DG, Mehta SH, Kirk GD. A prospective study of alcohol consumption and HIV acquisition among injection drug users. AIDS. 2011;25:221-228.
20. Vlahov D, Anthony J, Muñoz A, et al. The ALIVE Study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods. NIDA Res Monogr. 1991;109:75-100.
21. Howe CJ, Cole SR, Westreich DJ, Greenland S, Napravnik S, Eron JJ Jr. Splines for trend analysis and continuous confounder control [Research Letter]. Epidemiology. 2011;22:874-875.
22. Li R, Chambless L. Test for additive interaction in proportional hazards models. Ann Epidemiol. 2007;17:227-236.
23. Baliunas D, Rehm J, Irving H, Shuper P. Alcohol consumption and risk of incident human immunodeficiency virus infection: a meta-analysis. Int J Public Health. 2010;55:159-166.
24. Hernán MA. The hazards of hazard ratios [Commentary]. Epidemiology. 2010;21:13-15.
25. Cole SR, Hernán MA. Fallibility in estimating direct effects. Int J Epidemiol. 2002;31:163-165.
26. Hernán MA, Hernandez-Diaz S, Robins JM. A structural approach to selection bias. Epidemiology. 2004;15:615-625.
27. Robins J. A graphical approach to the identification and estimation of causal parameters in mortality studies with sustained exposure periods. J Chronic Dis. 1987;40(suppl 2):139S-161S.
28. Cole SR, Hernán MA. Constructing inverse probability weights for marginal structural models. Am J Epidemiol. 2008;168:656-664.
29. Howe CJ, Cole SR, Chmiel JS, Munoz A. Limitation of inverse probability-of-censoring weights in estimating survival in the presence of strong selection bias. Am J Epidemiol. 2011;173:569-577.
30. Robins JM. Structural nested failure time models. In: Survival Analysis. Andersen PK, Keiding N, section eds. In: Armitage P, Colton T, eds. The Encyclopedia of Biostatistics. Chichester, United Kingdom: John Wiley & Sons; 1998:4372-4389.
31. Petersen ML, Deeks SG, Martin JN, Van der Laan MJ. History-adjusted marginal structural models for estimating time-varying effect modification. Am J Epidemiol. 2007;166:985-993.
32. Cain LE, Robins JM, Lanoy E, Logan R, Costagliola D, Hernán MA. When to start treatment? A systematic approach to the comparison of dynamic regimes using observational data. Int J Biostat. 2010;6:Article 18.